Table 2.
Demographic of subjects with and without respiratory viral infections (RVI)
| RVI | No RVI | P‐value 1 | |||
|---|---|---|---|---|---|
| N | (%) | N | (%) | ||
| Age at transplant (years) | 79 | 9.7 (1.7, 13.2) 2 | 495 | 13.1 (9.0, 16.1) 2 | <0.001 3 |
| Female | 49 | 62.0 | 281 | 56.5 | 0.36 |
| Caucasian | 66 | 83.5 | 448 | 90.6 | 0.052 |
| Cystic fibrosis | 22 | 27.8 | 284 | 57.3 | <0.001 |
| Transplant type | 0.028 4 | ||||
| Single left or right | 1 | 1.3 | 13 | 2.6 | |
| Bilateral cadaveric | 65 | 82.3 | 335 | 67.5 | |
| Heart and lung transplant | 9 | 11.4 | 125 | 25.2 | |
| Living donor | 4 | 5.0 | 23 | 4.6 | |
| No induction therapy | 52 | 65.8 | 250 | 54.6 | 0.012 |
| Home‐going regimen: cyclosporine | 64 | 81.0 | 349 | 70.2 | 0.048 |
χ2 test.
2 Median (25, 75).
3 Wilcoxon's rank‐sum test.
4 Fisher's exact test.